Project Grant R01AI190177
Award Date
5/13/25
Completion Date
4/30/30
Dollars Obligated
$1.6M
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $210,867 in funding to Drexel University to develop a novel cell-based therapy for generating donor-specific immune tolerance in kidney transplant recipients. The key focus is on engineering potent tolerogenic dendritic cells (toldcs) containing microparticles loaded with a synergistic combination of...
This Project Grant award of $612,975 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to advance long-term allograft acceptance in organ transplantation. The key objectives are to: 1) Develop a translational model that combines T cell costimulation blockade with inhibition of monocyte allorecognition via CD47 to induce long-term graft acceptance, and 2) Investigate the mechanisms of monocyte...
The University of Pittsburgh received a $679,937 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct research on mechanisms and therapeutic targeting of T cell regulation in heart allograft recipient monkeys. The 5-year project aims to investigate the impact of cytokine modulation and administration of novel, donor-specific chimeric antigen receptor regulatory T cells (CARTREG) on promoting long-term...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $365,625 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant aims to investigate the role of fibroblast activation protein (FAP) in chronic rejection and fibrosis of organ transplant allografts. The research seeks to define FAP expression during...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $644,770 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Trustees of the University of Pennsylvania (UPenn) on May 7, 2025. The project aims to determine the effects of immunosuppression on the risk of post-transplant lymphoproliferative disorder (PTLD) and Epstein-Barr virus (EBV) infection in EBV-seronegative kidney transplant recipients of EBV-seropositive donor organs....
This federal Project Grant award of $1,286,273.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop clinically applicable protocols for inducing tolerance in liver transplant recipients. The primary objectives are: To test the ability of BCL-2 inhibitors to promote durable chimerism for simultaneous bone marrow and liver transplants while reducing the toxicity of the induction regimen,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,074,434.37 Project Grant to the Massachusetts General Hospital under the Allergy and Infectious Diseases Research program (CFDA 93.855) on March 17, 2021 with a completion date of July 12, 2021. The grant funding supports research to develop protocols to induce tolerance in non-human primate heart allograft recipients without chronic immunosuppression. The awardee will test approaches to either...
This $3,137,205.00 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is focused on developing and applying a computational drug repositioning pipeline to identify novel single and combination therapeutics for the treatment of antibody-mediated renal allograft rejection (ABMR) in kidney transplant recipients. The key products and services to be delivered include:...
This federal Project Grant award of $350,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop polymer-derived biomaterials for messenger RNA (mRNA) delivery to induce antigen-specific immune tolerance. The award supports research to evaluate diverse nanocarrier formulations encapsulating antigens and mRNAs encoding tolerogenic proteins, investigate the biodistribution and...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to assess whether serum miRNA profiling can assist in safely tapering immunosuppression for liver transplant recipients. The $264,596 award will support a prospective randomized study to evaluate the use of miRNA biomarkers to personalize immunosuppression management and reduce the risk of rejection. The study will...